Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.53 beats by $0.12. Revenue of $183.7M misses by $0.1M....

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor
Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.53 beats by $0.12. Revenue of $183.7M misses by $0.1M. (PR)